Immunotherapy Master Trial for Advanced Cancers

Clinical trial NCT07431073 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07431073
Sponsor: UNICANCER
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced / Metastatic Solid Tumors Advanced Malignancy

Start date: 2026-07-01
Primary completion: 2028-06-01
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.